Health care; requiring licensed practitioners to offer pharmacogenomic test prior to prescription of psychotropic drugs. Effective date.

SB 29 requires licensed healthcare providers in Oklahoma to offer pharmacogenomic testing to patients before prescribing psychotropic medications (like antidepressants or antipsychotics). This applies to all patients receiving such prescriptions and mandates providers to explain the test's benefits, confirm if it's FDA-approved, provide a cost estimate, and obtain the patient's informed consent. If consent is given, the test must be administered before the medication is prescribed. The law takes effect on November 1, 2025, aiming to personalize treatment based on genetic factors affecting drug response.